Alpha Teknova, Inc. TKNO revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Alpha Teknova, Inc. reported revenue across 3 products and services; the largest, Lab Essentials, was $31M, 76.6% of the filed sum (+7.5% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Lab Essentials$31M76.6%+7.5% yoy
- Clinical Solutions$7.65M18.9%+7.8% yoy
- Other Product$1.83M4.5%+3.5% yoy
Members sum to the consolidated $40.5M for this period.
- United States$38.2M94.4%+6.5% yoy
- Outside the United States$2.27M5.6%+24.4% yoy
Members sum to the consolidated $40.5M for this period.
- Lab Essentials$8.39M75.8%+3.4% yoy
- Clinical Solutions$2.15M19.4%+84.6% yoy
- Other Product$537K4.8%+4.1% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.